Table 2. Analysis of the quality of evidence (GRADE) in relation to the overall rate of occurrence of the assessed outcomes.
Certainty assessment | Patients (n) | Certainty of evidence | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Outcome follow-up | Studies (n) | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Others considerations | OAGB | Control | |
BMI at 6-month | 3 | RCT | VS | Serious (I2>50) |
NS | VS | None | 78 | 80 | ⊕⭘⭕⭕ Very low |
BMI at 1-year | 4 | RCT | VS | NS | NS | Serious | None | 117 | 129 | ⊕⭘⭕⭕ Very low |
BMI at 5-year | 2 | RCT | VS | NS | NS | Serious | None | 82 | 90 | ⊕⭘⭕⭕ Very low |
%EWL at 1-year | 4 | RCT | VS | Serious (I2>50) |
NS | NS | None | 129 | 139 | ⊕⭘⭕⭕ Very low |
%EWL at 5-year | 2 | RCT | VS | Serious (I2>50) |
NS | VS | None | 82 | 90 | ⊕⭘⭕⭕ Very low |
BMI: body mass index; OAGB: one anastomosis gastric bypass; RCT: randomized controlled trial; VS: very serious; NS: not serious; EWL: excess weight loss.